Professional Documents
Culture Documents
Special Issue of National E- Conference on Role of Nanotechnology for Sustainable Future on 31 Aug. 2021 10
Vidyabharati International Interdisciplinary Research Journal (Special Issue) ISSN 2319-4979
of the drug, Cheaper and stable, Provide 9.4% new colorectal cancer cases are attributed
patient compliance[8, 9]. to the consumption of alcohol, globally [15].
Nanotechnology Radiation
Nanotechnology is the preparation of In the developed and developing countries, the
Nanosized structures containing the API [10]. radiations are also notorious carcinogens.
Nanotechnology is defined because the study About 10% cancer occurrence is due to
and use of structures within the size range of radiation effect, both ionizing and non-
1 to 100 nm. The goal of nanotechnology is ionizing. The major sources of radiations are
to diagnose as accurately and early as radioactive compounds, ultraviolet [UV] and
possible and to treat as effectively as pulsed electromagnetic fields. [13]
possible with none adverse effects using
Plant as a Source of Anti-cancer
controlled and targeted drug delivery
Compounds
approach [11].
Important Drug Delivery System developed Plant derived compounds, which are the
using Nanotechnology principles are Nano important source of clinically useful anti-
particles, Solid Lipid Nano particles, Nano cancer drug, has shown to have probable for
suspension, Nano emulsion, Nano crystals treatment or prevention of cancer in humans.
[12]. In the treatment of cancer, plant features
a long history; quite 3000 plant
Types of Cancers species are reported by Hartwell which
*Carcinomas are utilized in treatment of cancer. [17]
*Sarcoma Plants also as plant derived compounds have
*Lymphomas played significant role within
* Leukemias the development of variety of clinically used
*Adenomas anti-cancer agents. Chemotherapy, being a
serious treatment used for the control of
Factors Influencing Cancer
advanced stages of malignancies and as a
*Age:
prophylactic against possible metastasis,
Cancer most commonly develops in older
exhibits severe toxicity on normal tissues.
people; 78% of all cancer diagnoses are in
Plants are used for treating various diseases
people 55 years of
of citizenry and animals. They maintain the
age or older. Anyone can develop cancer.
health and vitality of people and also cure
However, the risk of being diagnosed with
diseases, including cancer without causing
cancer increases significantly with age.
toxicity. More than 50% of all modern drugs
*Obesity and Physical activity in clinical use are of natural products, many
Obesity and lack of physical activity are of which have the ability to control cancer
associated with increased risk at various cancer cells. [18].
sites, including breast and endometrial cancer. Influence of Aging on Drug
[14] Pharmacokinetics
Tobacco and Smoking With increasing age, multiple physiological
The consumption of tobacco is the leading parameters alter, which can substantially
cause of cancers. The regular use of tobacco influence the PK of anticancer drugs. In
via smoking, chewing, snuffing, which is elderly patients, the PK profile can be
responsible for 65% to 85% cancer influenced by changed distribution,
incidences in men and women, respectively. metabolism and elimination parameters,
[15] while changes in absorption rarely led to
Alcohol consumption clinically-relevant differences. Changes in
gastric pH may have variable impacts on
Alcohol consumption also considered as one of anticancer drug absorption, while
the major cause of colorectal cancer as per a absorption of sophistication II oral
recent monograph of WHO. Annually, about therapeutic drugs, including tyrosine kinase
Special Issue of National E- Conference on Role of Nanotechnology for Sustainable Future on 31 Aug. 2021 11
Vidyabharati International Interdisciplinary Research Journal (Special Issue) ISSN 2319-4979
References
1. Walker R, Edwards C. (2003). The Jaypee Brothers Medical Publishers [P] Ltd
Textbook of Clinical pharmacy and 265-353.
Therapeutics, Third Edition. New Delhi, 2. Peppa LB, Blanchette JO, (2004).
Nanoparticle and targeted system for
Special Issue of National E- Conference on Role of Nanotechnology for Sustainable Future on 31 Aug. 2021 12
Vidyabharati International Interdisciplinary Research Journal (Special Issue) ISSN 2319-4979
cancer therapy. Adv Drug Deliv. Rev. 12. Maravajhala V. (2011). Nanotechnology in
56:1649-59. Development of Drug Delivery System.
3. Lee RJ, Low PS. (1995). Folate-mediated International Journal of Pharmaceutical
tumor cell targeting of liposome-entrapped Science and Research 3: 84-96.
doxorubicin in vitro. Biochem Biophys 13. Sharma R., Jain S., (2014). “Cancer
Acta 1233:134-144. Treatment: An Overview of Herbal
4. Sinha R, Anderson DE, McDonald SS, Medicines” WJPPS, 3: 224.
Greenwald P. (2003). “Cancer Risk and 14. Sinha R, Anderson DE, McDonald SS,
Diet in India” J Postgrad Med., 49: 222- Greenwald P, (2003). “Cancer Risk and
228. Diet in India” J Postgrad Med., 49: 222-
5. Kreuter J, (2007). Nanoparticles-a 228.
historical perspective. Int J Pharm. 331:1- 15. Imran Ali, Waseem A. Wani and Kishwar
10. Saleem, 2011. “Cancer Scenario in India
6. Mohanraj VJ, Chen Y. (2006). with Future Perspectives” Cancer
Nanoparticles – A Review. Trop J Pharm Therapy, 8: 56-70.
Res. 5 [1]:561-73 16. Kharb Manju, Jat R.K. and Gupta A.
7. Soppimath KS, Aminabhavi TM, (2012). “A Review on Medicinal Plants
Kulkarni AR. (2001). Biodegradable Used As A Source of Anticancer Agents”
polymeric nanoparticles as drug delivery International Journal of Drug Research
devices. J Control Release. 70: 1 –20. and Technology, 2[2]: 177-183.
8. Gelperina S, Kisich K, Heifets L.The 17. Alam S., Satpathy P., Thosar A. (2014).
Potential Advantages of Nanoparticle Drug “Plants And Its Parts As A Source Of Anti-
Delivery Systems in Chemotherapy of Cancer Compounds: A Review” IRJP, 5[4]:
Tuberculosis. (2005). Am J Respir Crit 244-245.
Care Med. 172[12]: 1487–1490. 18. Kaur R., Singh J., Singh G., Kaur H.,
9. Marcato PD, Duran N. (2008). New (2011). “Anticancer Plants: A Review” J.
Aspects of Nanopharmaceutical Delivery Nat. Prod. Plant Resour., 1[4]: 131-136.
Systems. J Nanosci Nanotechnol. 8[5]:1- 19. Srokowski, T.P., Fang, S., Hortobagyi,
149. G.N., Giordano, S.H. (2009). Impact of
10. Loxley A. (2009). Solid Lipid diabetes mellitus on complications and
Nanoparticles for the Delivery of outcomes of adjuvant chemotherapy in
Pharmaceutical Actives. Drug Delivery older patients with breast cancer. J.
Technology 8-32. Clin. Oncol. 27, 2170–2176.
11. Mishra B. (2010). Colloidal nanocarriers: a 20. Satariano,W.A., Ragland, D.R. (1994).
review on formulation technology, types The effect of comorbidity on 3-year
and applications toward targeted drug survival of women with primary breast
delivery. Nanomedicine NMB e9-e24. cancer. Ann. Intern. Med. 120, 104–110.
Special Issue of National E- Conference on Role of Nanotechnology for Sustainable Future on 31 Aug. 2021 13